PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer-Reference-Cited by-同舟云学术

PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer

Published:2018-02-16 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Li Qiongshu¹,Liu Muyun¹,Wu Man¹,Zhou Xin¹,Wang Shaobin²,Hu Yuan¹,Wang Youfu¹,He Yixin¹,Zeng Xiaoping¹,Chen Junhui²,Liu Qubo¹,Xiao Dong³,Hu Xiang¹,Liu Weibin¹

Affiliation:

1. Shenzhen Beike Cell Engineering Research Institute, Shenzhen, Guangdong 518057, P.R. China

2. Interventional and Minimally Invasive Oncology Therapy Department, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518035, P.R. China

3. Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer;Frontiers in Immunology;2023-08-25

2. Current Advancements and Future Perspectives of Immunotherapy in Breast Cancer Treatment;Immuno;2023-05-30

3. Protective Effect and Mechanism of Placenta Extract on Liver;Nutrients;2022-11-29

4. Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects;Cellular Oncology;2022-08-09

5. Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms;Pharmaceutics;2022-07-11